Cytokinetics (CYTK) Change in Accured Expenses (2016 - 2025)
Historic Change in Accured Expenses for Cytokinetics (CYTK) over the last 15 years, with Q4 2024 value amounting to $10.1 million.
- Cytokinetics' Change in Accured Expenses fell 6863.58% to $10.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $14.2 million, marking a year-over-year decrease of 1707.89%. This contributed to the annual value of $14.2 million for FY2024, which is 1707.89% down from last year.
- Cytokinetics' Change in Accured Expenses amounted to $10.1 million in Q4 2024, which was down 6863.58% from $5.5 million recorded in Q3 2024.
- Over the past 5 years, Cytokinetics' Change in Accured Expenses peaked at $32.1 million during Q4 2023, and registered a low of -$11.4 million during Q2 2023.
- For the 5-year period, Cytokinetics' Change in Accured Expenses averaged around $3.2 million, with its median value being $3.3 million (2020).
- Within the past 5 years, the most significant YoY rise in Cytokinetics' Change in Accured Expenses was 925356.13% (2023), while the steepest drop was 28795.85% (2023).
- Cytokinetics' Change in Accured Expenses (Quarter) stood at $1.5 million in 2020, then fell by 15.83% to $1.2 million in 2021, then tumbled by 128.33% to -$351000.0 in 2022, then soared by 9253.56% to $32.1 million in 2023, then tumbled by 68.64% to $10.1 million in 2024.
- Its Change in Accured Expenses was $10.1 million in Q4 2024, compared to $5.5 million in Q3 2024 and $4.2 million in Q2 2024.